Ricerc@Sapienza

Endovascular treatment of peripheral artery disease (PAD) has become the standard of care for TransAtlantic Inter-Society Consensus II A,B patients, although no evidence exists as to which procedures are preferred for each lesion type, and numerous different approaches could be employed.1 The latest trend in this field is to revascularize the limb without stent deployment by means of angio-modeling,2 atherectomy,3 or drug-coated balloon angioplasty.4 Despite these efforts a certain number of patients with relatively short lesions will experience residual stenosis, elastic recoil, or resteno

Aims: To establish the value of the SYNTAX Score-II (SS-II) in predicting long-term mortality of patients treated with left main PCI (LM-PCI) using second-generation drug-eluting stents (DES). Methods and Results: The SYNTAX score (SS) and the SS-II were calculated in 804 patients included in the FAILS-2 registry (failure in left main study with 2nd generation stents). Patients were classified in low (SS-II ≤33; n = 278, 34.6%), intermediate (SS-II 34–43; n = 260, 32.3%) and high (SS-II ≥44; n = 266, 33.1%) SS-II tertiles. Primary endpoint was all-cause mortality.

OBJECTIVES: Surgery for vascular anomalies can occasionally fail to relieve symptoms, especially when severe tracheobronchial malacia persists. We studied outcomes in children who underwent airway stenting for severe post-surgical airway malacia and tested known clinical and surgical prognostic factors. METHODS: Among 257 children evaluated for tracheobronchial vascular compression, we reviewed the clinical charts for the 59 patients (23%) who underwent surgery. After surgery, children in whom severe malacia and respiratory symptoms persisted underwent airway stenting.